Jul 29, 2021 / 12:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to Ajanta Pharma Limited Q1 FY22 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Yogesh Agarwal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you sir.
Yogesh Agarwal - Ajanta Pharma Limited - MD
Thank you. Good evening, and welcome, everyone. With me, I have Mr. Rajesh Agarwal, our Joint Managing Director, and Mr. Arvind Agrawal, our CFO. So before we move on to the business our thoughts and prayers are with everyone who suffered the effects of the second wave of COVID and especially to those who have lost their loved ones.
Recognizing that vaccination was our best back to an early return to the normalcy. We started the vaccination drive across all our locations starting in March. This covered not only Ajantaites but also their family members and I'm happy to say that over 88% of our Ajantaites have been vaccinated with at least one shot. As we speak national vaccination program is also progressing
Q1 2022 Ajanta Pharma Ltd Earnings Call Transcript
Jul 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers